Exporter

EN
FR
Coagulation factor IX, recombinant
Statut de médicament essentiel
Description générale

Codes ATC
Type de médicament
Biological agent
Historique des statuts LME
Ajouté pour la première fois en 2025 (TRS 1064) pour Haemophilia B
Recommandations
Section
Coagulation factors
  • Parenteral > General injections > IV: 250 IU per mL in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection
Indications